Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.05)
# 461
Out of 5,240 analysts
37
Total ratings
56.25%
Success rate
48.57%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Eyenovia | Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 18, 2024 | |
United Therapeutics | Maintains: Strong Buy | 319 344 | 369.99 | -7.02% | 7 | Oct 31, 2024 | |
UroGen Pharma | Maintains: Strong Buy | 48 54 | 10.48 | 410.5% | 1 | Jun 14, 2024 | |
TG Therapeutics | Maintains: Strong Buy | 39 40 | 30.66 | 30.46% | 3 | May 2, 2024 | |
Liquidia | Maintains: Strong Buy | 15 30 | 11.57 | 159.29% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 9 | 5.59 | 52.06% | 4 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 122 173 | n/a | n/a | 3 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 16 | 8.53 | 87.57% | 1 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 1071 | 3.39 | 31492.92% | 2 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 17 23 | 0.35 | 6471.43% | 1 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 450 | n/a | n/a | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 51 | 4.6 | 1008.7% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | 8.2 | 95.12% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 4.95 | 809.09% | 1 | Jan 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | n/a | n/a | 1 | Feb 16, 2017 |